Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg).
In the present study, we demonstrate that intravenous immunoglobulin (IVIg) is capable of binding to variable (V) regions of anti-endothelial cell antibodies (AECA) of healthy donors and patients with systemic lupus erythematosus (SLE). Among V regions of AECAs, IVIg selectively recognized certain idiotypes expressed by the autoantibodies of a given individual, in the case of both natural and SLE-associated AECAs. These observations provide new and direct evidence that IVIg interacts idiotypically with V regions of autoantibodies and that the efficacy of such interaction depends on individual autoantibody specificity. Our findings may be relevant for the understanding of the mechanisms that control expression of natural autoantibody activity in serum and for that of the differences in response to IVIg therapy that are seen between patients with autoimmune disease.
Ronda
N
N
INSERM U28, Hôpital Broussais, Paris, France.
Haury
M
M
Nobrega
A
A
Coutinho
A
A
Kazatchkine
M D
MD
D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology*; D004730:Endothelium, Vascular / Q000276:immunology; D005903:Gliadin / Q000276:immunology; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007135:Immunoglobulin Variable Region / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*
D001323:Autoantibodies; D007130:Immunoglobulin Idiotypes; D007135:Immunoglobulin Variable Region; D016756:Immunoglobulins, Intravenous; D005903:Gliadin